UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

A review of systemic medications that may modulate the risk of glaucoma

Wu, A; Khawaja, AP; Pasquale, LR; Stein, JD; (2020) A review of systemic medications that may modulate the risk of glaucoma. Eye , 34 (1) pp. 12-28. 10.1038/s41433-019-0603-z. Green open access

[thumbnail of Khawaja Systemic meds and glaucoma review.final.pdf]
Preview
Text
Khawaja Systemic meds and glaucoma review.final.pdf - Accepted Version

Download (630kB) | Preview
[thumbnail of Khawaja systemic meds and glaucoma tables.final.pdf]
Preview
Text
Khawaja systemic meds and glaucoma tables.final.pdf - Accepted Version

Download (522kB) | Preview

Abstract

With increasing longevity, patients are developing more and more chronic diseases that require treatment with medications. Yet, it is not fully understood the extent by which these systemic medications affect ocular structures and whether they may increase or decrease the risk of sight-threatening ocular diseases. This review provides a summary of reported associations between different systemic medications and the risk of developing glaucoma or experiencing disease progression. Medication classes covered in this review that are known to or may modulate the risk of open-angle glaucoma include corticosteroids, beta blockers, calcium channel blockers, metformin, statins, selective serotonin reuptake inhibitors, bupropion, postmenopausal hormones, and cannabinoids. Medication classes addressed in this review that may increase the risk of angle closure glaucoma include anticholinergics, adrenergic agonists, certain classes of antidepressants, sulfonamides, and topiramate.

Type: Article
Title: A review of systemic medications that may modulate the risk of glaucoma
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41433-019-0603-z
Publisher version: https://doi.org/10.1038/s41433-019-0603-z
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Drug therapy, Epidemiology, Optic nerve diseases
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10089005
Downloads since deposit
56,908Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item